tirzepatide and celiac disease autoimmune disease: what the research actually shows About 1 in 100 people

The use of proton pump inhibitors (PPIs) has been associated with an increased risk of vitamin B12 deficiency, particular in older adults and those on long-term PPI therapy. Nutrition Reviews Duration-Dependent Risk Assessment The risk of B12 deficiency from PPIs grows with time

Abstract Chronic treatment with GLP-1R agonists may moderately lower blood pressure due to increased natriuresis and RAAS inhibition

Weight loss plateaus are common and dont necessarily indicate the medication stopped working

Algunos ensayos clnicos pequeos han reportado modestas reducciones de peso corporal (tpicamente 1-2 kg durante 12-24 semanas) con ciertas cepas probiticas, particularmente L